# CURE PHARMACEUTICAL Corp: Form D filings

CURE PHARMACEUTICAL Corp, a pharmaceuticals company in Oxnard, CA, filed 8 Form D notices with the SEC between 2012 and 2016. The latest, on October 31, 2016, reports $6 million sold of a $6 million offering to 42 investors.

Find out what CURE PHARMACEUTICAL Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CURE%20PHARMACEUTICAL%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CURE%20PHARMACEUTICAL%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcure-pharmaceutical-corp-1554289)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CURE%20PHARMACEUTICAL%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CURE%20PHARMACEUTICAL%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcure-pharmaceutical-corp-1554289)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1620 BEACON PLACE, Oxnard, CA, 93033
- Phone: (805) 824-0410
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: California
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1554289

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 31, 2016 | New notice | $6,033,963 | $6,033,963 | $0 | 42 | Nov 10, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000008/0001554289-16-000008-index.htm) |
| Oct 31, 2016 | Amendment | $2,000,000 | $2,000,000 | $0 | 1 | Jul 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000007/0001554289-16-000007-index.htm) |
| Oct 31, 2016 | New notice | $323,212 | $323,212 | $0 | 1 | Dec 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000006/0001554289-16-000006-index.htm) |
| Oct 31, 2016 | New notice | $250,000 | $250,000 | $0 | 1 | Jul 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000005/0001554289-16-000005-index.htm) |
| Oct 28, 2016 | New notice | $80,000 | $80,000 | $0 | 1 | Jun 17, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000003/0001554289-16-000003-index.htm) |
| Oct 28, 2016 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Jul 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428916000002/0001554289-16-000002-index.htm) |
| Mar 25, 2013 | New notice | Indefinite | $300,000 | Indefinite | 1 | Feb 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000155428913000002/0001554289-13-000002-index.htm) |
| Jul 18, 2012 | New notice | $958,568 | $958,568 | $0 | 12 | Jul 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554289/000114420412040012/0001144204-12-040012-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Edward Maliski | Director |  |
| Rob Davidson | Executive Officer, Director |  |
| Wayne Nasby | Director |  |
| Ian Sephton | Director |  |
| Vic Branstetter | Director |  |
| Mark Udell | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Oct 31, 2016](https://specstream.ai/data/form-d/week/2016-10-31) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what CURE PHARMACEUTICAL Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).